Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. A. Toth, H. Goldstein, A. Kis, L. Kunos, J. Varga, G. Losonczy, S. Vasas, E. Mendes, A. Wanner, G. Horvath (Budapest, Hungary; Miami, United States Of America). The effect of inhaled ciclesonide on airway blood flow. Eur Respir J 2013; 42: Suppl. 57, 3400

Member's Comments

No comment yet.

Related content which might interest you: Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Study design supporting the effectiveness of inhaled extra-fine beclomethasone/formoterol at the level of small airways of asthmatics Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Can forced oscillation technique parameters predict airway hyperresponsiveness to histamine? Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Benralizumab effect on blood basophil counts in adults with uncontrolled asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Efficacy and safety of indacaterol acetate on ICS background therapy in asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013